Cimetidine (type A/AB), Metformin Hcl , Oxiracetam,Ranitidine base, N-Cyano-N-[2-(5-methylimidazole-4-methylthio)ethyl]-S-methylisothiourea and Aspartame.
more >
Year of Establishment:
2006
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
Central/South America,Asia,Africa
Advantage Description: